Search

Your search keyword '"Adappa, Nithin D"' showing total 1,098 results
Start Over Author "Adappa, Nithin D"
1,098 results on '"Adappa, Nithin D"'

156. Determinants of Survival in Skull Base Chondrosarcoma: A National Cancer Database Study

Author

Merna, Catherine, primary, Lehrich, Brandon M., additional, Kshirsagar, Rijul S., additional, Eide, Jacob G., additional, Diaz-Aguilar, Luis Daniel, additional, Goshtasbi, Khodayar, additional, Yasaka, Tyler M., additional, Sahyouni, Ronald, additional, Palmer, James N., additional, Adappa, Nithin D., additional, Hsu, Frank P.K., additional, and Kuan, Edward C., additional

Published
2022
Full Text
View/download PDF

158. Steroid affected cytokines in aspirin‐exacerbated respiratory disease

Author

Tan, Li Hui, primary, Lin, Cailu, additional, Ungerer, Heather, additional, Kumar, Ankur, additional, Qatanani, Anas, additional, Adappa, Nithin D., additional, Palmer, James N., additional, Bosso, John V., additional, Reed, Danielle, additional, Cohen, Noam A., additional, and Kohanski, Michael A., additional

Published
2022
Full Text
View/download PDF

159. Deep learning classification of inverted papilloma malignant transformation using 3D convolutional neural networks and magnetic resonance imaging

Author

Liu, George S., primary, Yang, Angela, additional, Kim, Dayoung, additional, Hojel, Andrew, additional, Voevodsky, Diana, additional, Wang, Julia, additional, Tong, Charles C.L., additional, Ungerer, Heather, additional, Palmer, James N., additional, Kohanski, Michael A., additional, Nayak, Jayakar V., additional, Hwang, Peter H., additional, Adappa, Nithin D., additional, and Patel, Zara M., additional

Published
2022
Full Text
View/download PDF

160. The management of cystic fibrosis chronic rhinosinusitis: An evidenced‐based review with recommendations

Author

Spielman, Daniel B., primary, Beswick, Daniel M., additional, Kimple, Adam J., additional, Senior, Brent A., additional, Aanaes, Kasper, additional, Woodworth, Bradford A., additional, Schlosser, Rodney J., additional, Lee, Stella, additional, Cho, Do‐Yeon, additional, Adappa, Nithin D., additional, DiMango, Emily, additional, and Gudis, David A., additional

Published
2022
Full Text
View/download PDF

162. In-Hospital Costs Associated With an Expanded Endonasal Approach to Anterior Skull Base Tumors

Author

Parasher, Arjun K., primary, Lerner, David K., additional, Glicksman, Jordan T., additional, Lin, Theodore, additional, Miranda, Stephen P., additional, Ebesutani, Darren, additional, Kohanski, Michael, additional, Lee, John Y. K., additional, Storm, Phillip B., additional, O’Malley, Bert W., additional, Yosher, Daniel, additional, Palmer, James N., additional, Grady, Sean, additional, and Adappa, Nithin D., additional

Published
2022
Full Text
View/download PDF

164. Carcinosarcoma of the nasal cavity and paranasal sinuses: Review of the national cancer database

Author

Harris, Jacob C., Eide, Jacob G., Kshirsagar, Rijul S., Brant, Jason A., Palmer, James N., and Adappa, Nithin D.

Abstract

Carcinosarcomas are rare, aggressive malignancies that can arise in the nasal cavity and paranasal sinuses. There are limited outcome data available. Accordingly, we sought to use the National Cancer Database (NCDB) to characterize patient demographics and outcomes. A retrospective analysis of the NCDB from 2004 to 2016 for patients with sinonasal carcinosarcoma was conducted. Thirty patients were included. The patients were predominantly male (n= 20), white (n= 23), and privately insured (n= 15), with an average age of 62.4 years. The nasal cavity was the most common subsite (n= 14), followed by the maxillary sinus (n= 8). Most patient were treated with surgery followed by radiation (n= 23), with the remaining undergoing surgery alone (n= 4), radiation alone (n= 2), or no treatment (n= 1). One‐third (n= 10) received adjuvant chemotherapy. The 1‐ and 5‐year overall survival (OS) in the cohort were 79.2% and 43.3%, respectively. Univariate log‐rank testing showed OS varied based on intervention (P< 0.029), sex (P< 0.042), and age (P< 0.025), while on multivariate analysis none of these factors independently predicted OS. We describe the demographics and presenting features of a national cohort of sinonasal carcinosarcoma patients. Future research is needed to identify predictors of overall survival, and to assess the optimal roles for radiation and systemic chemotherapy. The demographics and outcomes for a cohort of 30 patients with sinonasal carcinosarcoma were described.Seventy‐six percent of patients were treated with surgery followed by adjuvant radiotherapy.1‐ and 5‐year survival from the time of diagnosis were 79.2% and 43.3% respectively.Neither surgical intervention, patient sex, nor patient age independently predicted survival outcomes. The demographics and outcomes for a cohort of 30 patients with sinonasal carcinosarcoma were described. Seventy‐six percent of patients were treated with surgery followed by adjuvant radiotherapy. 1‐ and 5‐year survival from the time of diagnosis were 79.2% and 43.3% respectively. Neither surgical intervention, patient sex, nor patient age independently predicted survival outcomes.

Published
2023
Full Text
View/download PDF

167. Comparison of high‐flow CSF leak closure with nasoseptal flap following endoscopic endonasal approach in adult and pediatric populations

Author

Papagiannopoulos, Peter, primary, Tong, Charles C.L., additional, Brown, Hannah J., additional, Douglas, Jennifer E., additional, Yver, Christina M., additional, Kuan, Edward C., additional, Tajudeen, Bobby A., additional, Kohanski, Michael A., additional, LeeMSCE, John Y. K., additional, Palmer, James N., additional, W.O'Malley, Bert, additional, Grady, M. Sean, additional, Storm, Phillip B., additional, and Adappa, Nithin D., additional

Published
2021
Full Text
View/download PDF

169. Bitter and sweet taste receptors regulate human upper respiratory innate immunity

Author

Lee, Robert J., Kofonow, Jennifer M., Rosen, Philip L., Siebert, Adam P., Chen, Bei, Doghramji, Laurel, Xiong, Guoxiang, Adappa, Nithin D., Palmer, James N., Kennedy, David W., Kreindler, James L., Margolskee, Robert F., and Cohen, Noam A.

Subjects
Respiratory organs -- Physiological aspects -- Research, Immune system -- Research -- Physiological aspects, Taste buds -- Physiological aspects -- Research, Physiological research -- Physiological aspects -- Research, Cardiopulmonary system -- Physiological aspects -- Research, Health care industry, Physiological aspects, Research
Abstract

Bitter taste receptors (T2Rs) in the human airway detect harmful compounds, including secreted bacterial products. Here, using human primary sinonasal air-liquid interface cultures and tissue explants, we determined that activation of a subset of airway T2Rs expressed in nasal solitary chemosensory cells activates a calcium wave that propagates through gap junctions to the surrounding respiratory epithelial cells. The T2R-dependent calcium wave stimulated robust secretion of antimicrobial peptides into the mucus that was capable of killing a variety of respiratory pathogens. Furthermore, sweet taste receptor (T1R2/3) activation suppressed T2R-mediated antimicrobial peptide secretion, suggesting that T1R2/3-mediated inhibition of T2Rs prevents full antimicrobial peptide release during times of relative health. In contrast, during acute bacterial infection, T1R2/3 is likely deactivated in response to bacterial consumption of airway surface liquid glucose, alleviating T2R inhibition and resulting in antimicrobial peptide secretion. We found that patients with chronic rhinosinusitis have elevated glucose concentrations in their nasal secretions, and other reports have shown that patients with hyperglycemia likewise have elevated nasal glucose levels. These data suggest that increased glucose in respiratory secretions in pathologic states, such as chronic rhinosinusitis or hyperglycemia, promotes tonic activation of T1R2/3 and suppresses T2R-mediated innate defense. Furthermore, targeting T1R2/3-dependent suppression of T2Rs may have therapeutic potential for upper respiratory tract infections., Introduction Mucociliary clearance is the primary physical defense against inhaled pathogens, toxins, and particulates in the respiratory system (1) and is complemented by the generation of antimicrobial peptides (AMPs) and [...]

Published
2014
Full Text
View/download PDF

170. Dupilumab Adverse Events in Nasal Polyp Treatment: Analysis of FDA Adverse Event Reporting System.

Author

Swisher, Austin R., Kshirsagar, Rijul S., Adappa, Nithin D., and Liang, Jonathan

Abstract

Objectives: Dupilumab was the first biologic approved to treat chronic rhinosinusitis with nasal polyps (CRSwNP). While the risk of adverse events in phase-III clinical trials was low, dupilumab-associated adverse reactions (DAR) with real-world use is unknown and potentially under-reported. We aimed to evaluate DAR for CRSwNP treatment (CRSwNP-tx) using the FDA Adverse Event Reporting System (FAERS). Study Design: Retrospective database study. Methods: FAERS was queried for DAR from 2019Q1 to 2021Q2. Individual DAR (iDAR) were categorized and quantitatively compared between treatment groups (CRSwNP, asthma, atopic dermatitis). Zero-truncated Poisson regression was modeled to predict the number of iDAR, and logistic regression was modeled to predict serious DARs. Results: There were 15,411 DAR observations; 911 for CRSwNP-tx, of which 121 (13.3%) had serious reactions and 3 died. Common CRSwNP-tx iDAR were dermatologic (13.9%), generalized (13.3%), and injection-site (10.8%) symptoms. The number of CRSwNP-tx iDAR was 2.99 [2.81, 3.17], compared to 3.44 [3.32, 3.56] for asthma and 3.18 [3.13, 3.24] for atopic dermatitis (Kruskal-Wallis test, P < .001). For CRSwNP-tx, iDAR reported-risk-ratio was 0.84 [0.77, 0.92] among men and 1.12 [1.04, 1.22] among older adults (>50). Serious DAR reported-odds-ratio was 1.37 [0.91, 2.04] among men and 1.39 [0.93, 2.08] among older adults. Conclusions: While there are limitations with FAERS, this analysis suggests CRSwNP-tx is associated with fewer iDAR compared with other treatment indications. More iDAR are experienced among women and older adults, but men tend to have more serious DAR. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

174. Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma

Author

Tong, Charles C. L., primary, Koptyra, Mateusz, additional, Raman, Pichai, additional, Rathi, Komal S., additional, Choudhari, Namrata, additional, Lin, Xiang, additional, Seckar, Tyler, additional, Wei, Zhi, additional, Kohanski, Michael A., additional, O'Malley, Bert W., additional, Cohen, Noam A., additional, Kennedy, David W., additional, Adappa, Nithin D., additional, Robertson, Erle S., additional, Baranov, Esther, additional, Kuan, Edward C., additional, Papagiannopoulos, Peter, additional, Jalaly, Jalal B., additional, Feldman, Michael D., additional, Storm, Phillip B., additional, Resnick, Adam C., additional, and Palmer, James N., additional

Published
2021
Full Text
View/download PDF

176. Prognosis of Distant Metastatic Sites in Anterior Skull Base Malignancies.

Author

Kraft, Daniel O., Carey, Ryan M., Prasad, Aman, Rajasekaran, Karthik, Kohanski, Michael A., Kennedy, David W., Palmer, James N., Adappa, Nithin D., Newman, Jason G., and Brant, Jason A.

Subjects
LUNGS, SKULL base, PROPORTIONAL hazards models, ADENOID cystic carcinoma, PROGNOSIS, OVERALL survival, SURVIVAL rate
Abstract

Objective  This study aimed to provide information regarding the prognosis of patients presenting with metastatic anterior skull base malignancies based upon histology and site of distant metastasis (DM). Patients and Methods  The National Cancer Database was queried for patients with anterior skull base malignant neoplasms with DM. Outcomes  Prognosis was compared between site of DM and tumor histologies. A multivariable Cox proportional hazards model was used to identify prognostic factors for overall survival (OS). Results  A total of 481 patients were identified. Lung was the most common site of DM (24.9%), followed by bone (22.2%), liver (5.6%), and brain (2.5%). Lung was the most common site for squamous cell carcinoma (SCCa) (28.3%), melanoma (37.7%), and adenoid cystic carcinoma (ACC; 31.4%). The median survival for patients presenting with metastatic disease regardless of tumor histology was 9.0 months (95% confidence interval [CI]: 8.2–10.3), and patients with metastasis to the liver had the best median survival at 15.5 months (95% CI: 10.5–25.6). The median survivals for the most common histologies, SCCa, melanoma, and ACC were 8.2 months (95% CI: 5.5–10.2), 10.5 months (95% CI: 8.7–14.1), and 15.0 months (95% CI: 11.1–61.1), respectively. Multivariable analysis demonstrated worse overall survival (OS) for older patients, higher Charlson-Deyo comorbidity scores, and tumors with higher grade and T stage. Compared with metastasis to bone, lung metastasis had better OS on multivariable analysis (hazard ratio [HR]: 0.70, 95% CI: 0.51–97). Adenoid cystic carcinoma had improved OS compared with SCCa (HR: 0.62, 95% CI: 0.39–99). Conclusion  Tumor histology, metastatic sites, and several disease factors affected prognosis in anterior skull base malignancies with DM. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

177. A Systematic Review of Definitive Treatment for Inverted Papilloma Attachment Site and Associations With Recurrence.

Author

Trent, Monica S., Goshtasbi, Khodayar, Hui, Lily, Stuyt, John A. Gerka, Adappa, Nithin D., Palmer, James N., and Kuan, Edward C.

Abstract

Objective: Inverted papilloma (IP) is the most common benign neoplasm of the nasal cavity with known risk of recurrence. There is no standardized approach to definitive treatment for attachment sites. This systematic review aims to determine whether surgeon choice of technique differs by anatomic attachment site and whether different surgical techniques contribute to reduced rates of recurrence. Data Sources: PubMed and Ovid Medline. Review Methods: A systematic review was conducted for studies reporting on IP. Those that included IP recurrence rates and primary tumor attachment site were reviewed. Results: Of 122 published studies, 14 met eligibility criteria, representing 585 patients and a recurrence rate of 5.8%. The maxillary sinus (50.9%) was the most common primary attachment site, and the sphenoid sinus was associated with the highest rate of recurrence (10.4%). The most utilized technique included debulking the tumor, removing mucosa over the attachment site, and drilling the underlying bone. The most common Krouse stage represented was T3 (53.3%). No single technique predicted a propensity for recurrence, but certain techniques are favored depending on IP attachment site. Finally, frozen sections to obtain evidence of clear margins intraoperatively significantly reduced rates of recurrence (3.4% vs 7.3%, P =.045). Conclusion: Based on the current literature, the most common technique to address site of attachment involves resecting mucosa and drilling the tumor base. Choice of technique appears to differ for various sites of attachment. Use of intraoperative frozen section analysis appears to be associated with decreased recurrence overall. Level of Evidence: 3. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

178. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection

Author

Lee, Robert J., Xiong, Guoxiang, Kofonow, Jennifer M., Chen, Bei, Lysenko, Anna, Jiang, Peihua, Abraham, Valsamma, Doghramji, Laurel, Adappa, Nithin D., Palmer, James N., Kennedy, David W., Beauchamp, Gary K., Doulias, Paschalis-Thomas, Ischiropoulos, Harry, Kreindler, James L., Reed, Danielle R., and Cohen, Noam A.

Subjects
Taste buds -- Genetic aspects, Genetic polymorphisms -- Identification and classification, Cell culture -- Usage, Respiratory tract infections -- Diagnosis -- Care and treatment -- Genetic aspects, Health care industry
Abstract

Innate and adaptive defense mechanisms protect the respiratory system from attack by microbes. Here, we present evidence that the bitter taste receptor T2R38 regulates the mucosal innate defense of the human upper airway. Utilizing immunofluorescent and live cell imaging techniques in polarized primary human sinonasal cells, we demonstrate that T2R38 is expressed in human upper respiratory epithelium and is activated in response to acyl-homoserine lactone quorum-sensing molecules secreted by Pseudomonas aeruginosa and other gram-negative bacteria. Receptor activation regulates calcium-dependent NO production, resulting in stimulation of mucociliary clearance and direct antibacterial effects. Moreover, common polymorphisms of the TAS2R38 gene were linked to significant differences in the ability of upper respiratory cells to clear and kill bacteria. Lastly, TAS2R38 genotype correlated with human sinonasal gram-negative bacterial infection. These data suggest that T2R38 is an upper airway sentinel in innate defense and that genetic variation contributes to individual differences in susceptibility to respiratory infection., Introduction Inhaled pathogens, toxins, and particulates continuously challenge the respiratory system. The principal physical defense against these inhaled insults is mucociliary clearance (MCC), which has 2 components, mucus production and [...]

Published
2012
Full Text
View/download PDF

179. Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study

Author

Beswick, Daniel M., primary, Hwang, Peter H., additional, Adappa, Nithin D., additional, Le, Christopher H., additional, Humphreys DO, Ian M., additional, Getz, Anne E., additional, Suh, Jeffrey D., additional, Aasen, Davis M., additional, Abuzeid, Waleed M., additional, Chang, Eugene H., additional, Kaizer, Alexander M., additional, Kindgom, Todd T., additional, Kohanski, Michael A., additional, Nabavizadeh, Seyed Ali, additional, Nayak, Jayakar V., additional, Palmer, James N., additional, Patel, Zara M., additional, Ramakrishnan, Vijay R., additional, Snyderman, Carl H., additional, St. John, Maie A., additional, Wild, Jessica, additional, and Wang, Eric W., additional

Published
2021
Full Text
View/download PDF

181. The GSDMB rs7216389 SNP is associated with chronic rhinosinusitis in a multi‐institutional cohort

Author

Zack, Dana E., primary, Stern, Debra A., additional, Willis, Amanda L., additional, Kim, Alexander S., additional, Mansfield, Corinne J., additional, Reed, Danielle R., additional, Brooks, Steven G., additional, Adappa, Nithin D., additional, Palmer, James N., additional, Cohen, Noam A., additional, Chiu, Alexander G., additional, Song, Brian H., additional, Le, Chris H., additional, and Chang, Eugene H., additional

Published
2021
Full Text
View/download PDF

185. Utilizing Histopathology to Predict Success with Macrolide Therapy in CRS Patients.

Author

Workman, Alan D., Chang, Jeremy, Lerner, David K., Wilensky, Jadyn, Montone, Kathleen T., Bosso, John V., Palmer, James N., Adappa, Nithin D., and Kohanski, Michael A.

Abstract

This article discusses the use of histopathology to predict the success of macrolide therapy in patients with chronic rhinosinusitis (CRS). The study analyzed a cohort of over fifty CRS patients who were on macrolide therapy, and examined the histopathological findings at the time of surgery to determine their association with the success of macrolide treatment. The findings showed that fibrosis, absence of squamous metaplasia, absence of eosinophilia, presence of neutrophilic infiltrate, and lymphoplasmocytic predominance were all associated with the objective success of macrolide treatment. These findings may help clinicians in selecting appropriate patients for macrolide therapy. [Extracted from the article]

Published
2024
Full Text
View/download PDF

186. Long‐Term Outcomes in Pediatric Midfacial Growth Following Expanded Endonasal Skull Base Surgery for Craniopharyngioma.

Author

Douglas, Jennifer E., Lee, Daniel J., Sell, Elizabeth, Parasher, Arjun K., Lerner, David K., Lazor, Jillian W., Kohanski, Michael A., Lee, John Y.K., Storm, Phillip B., Palmer, James N., and Adappa, Nithin D.

Abstract

This article discusses the long-term outcomes of midfacial growth in pediatric patients who underwent expanded endonasal skull base surgery for craniopharyngioma. The study compared the cephalometric measurements of patients who underwent the endoscopic approach with those who underwent an open transcranial approach. The results showed no significant difference in midfacial growth between the two groups, suggesting that the endoscopic approach is safe and efficacious for pediatric patients without concerns for long-term craniofacial growth. Further research with larger cohorts is needed to better understand the long-term clinical implications of pediatric endoscopic skull base surgery. [Extracted from the article]

Published
2024
Full Text
View/download PDF

187. Cilia Stimulatory and Antibacterial Activities of T2R Bitter Taste Receptor Agonist Diphenhydramine: Insights into Repurposing Bitter Drugs for Nasal Infections.

Author

Kuek, Li Eon, McMahon, Derek B., Ma, Ray Z., Miller, Zoey A., Jolivert, Jennifer F., Adappa, Nithin D., Palmer, James N., and Lee, Robert J.

Subjects
TASTE receptors, BITTERNESS (Taste), DIPHENHYDRAMINE, CILIA & ciliary motion, MUCOCILIARY system, DRUG repositioning, ANTIBACTERIAL agents, GENTIAN violet
Abstract

T2R bitter taste receptors in airway motile cilia increase ciliary beat frequency (CBF) and nitric oxide (NO) production. Polymorphisms in some T2Rs are linked to disease outcomes in chronic rhinosinusitis (CRS) and cystic fibrosis (CF). We examined the expression of cilia T2Rs during the differentiation of human nasal epithelial cells grown at air–liquid interface (ALI). The T2R expression increased with differentiation but did not vary between CF and non-CF cultures. Treatment with Pseudomonas aeruginosa flagellin decreased the expression of diphenhydramine-responsive T2R14 and 40, among others. Diphenhydramine increased both NO production, measured by fluorescent dye DAF-FM, and CBF, measured via high-speed imaging. Increases in CBF were disrupted after flagellin treatment. Diphenhydramine impaired the growth of lab and clinical strains of P. aeruginosa, a major pathogen in CF and CF-related CRS. Diphenhydramine impaired biofilm formation of P. aeruginosa, measured via crystal violet staining, as well as the surface attachment of P. aeruginosa to CF airway epithelial cells, measured using colony-forming unit counting. Because the T2R agonist diphenhydramine increases NO production and CBF while also decreasing bacterial growth and biofilm production, diphenhydramine-derived compounds may have potential clinical usefulness in CF-related CRS as a topical therapy. However, utilizing T2R agonists as therapeutics within the context of P. aeruginosa infection may require co-treatment with anti-inflammatories to enhance T2R expression. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

188. Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey

Author

Locke, Tran B., primary, Sweis, Auddie M., additional, Douglas, Jennifer E., additional, Ig-Izevbekhai, Kevin I., additional, Stevens, Elizabeth M., additional, Civantos, Alyssa M., additional, McCarty, Elizabeth B., additional, Kumar, Ankur, additional, Kohanski, Michael A., additional, Kennedy, David W., additional, Palmer, James N., additional, Bosso, John V., additional, and Adappa, Nithin D., additional

Published
2021
Full Text
View/download PDF

190. Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease

Author

Sweis, Auddie M., primary, Locke, Tran B., additional, Ig-Izevbekhai, Kevin I., additional, Lin, Theodore C., additional, Kumar, Ankur, additional, Douglas, Jennifer E., additional, Corr, Andrew M., additional, Civantos, Alyssa M., additional, Tripathi, Siddhant H., additional, Kennedy, David W., additional, Kohanski, Michael A., additional, Palmer, James N., additional, Adappa, Nithin D., additional, and Bosso, John V., additional

Published
2021
Full Text
View/download PDF

195. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer

Author

Petralia, Francesca, primary, Tignor, Nicole, additional, Reva, Boris, additional, Koptyra, Mateusz, additional, Chowdhury, Shrabanti, additional, Rykunov, Dmitry, additional, Krek, Azra, additional, Ma, Weiping, additional, Zhu, Yuankun, additional, Ji, Jiayi, additional, Calinawan, Anna, additional, Whiteaker, Jeffrey R., additional, Colaprico, Antonio, additional, Stathias, Vasileios, additional, Omelchenko, Tatiana, additional, Song, Xiaoyu, additional, Raman, Pichai, additional, Guo, Yiran, additional, Brown, Miguel A., additional, Ivey, Richard G., additional, Szpyt, John, additional, Guha Thakurta, Sanjukta, additional, Gritsenko, Marina A., additional, Weitz, Karl K., additional, Lopez, Gonzalo, additional, Kalayci, Selim, additional, Gümüş, Zeynep H., additional, Yoo, Seungyeul, additional, da Veiga Leprevost, Felipe, additional, Chang, Hui-Yin, additional, Krug, Karsten, additional, Katsnelson, Lizabeth, additional, Wang, Ying, additional, Kennedy, Jacob J., additional, Voytovich, Uliana J., additional, Zhao, Lei, additional, Gaonkar, Krutika S., additional, Ennis, Brian M., additional, Zhang, Bo, additional, Baubet, Valerie, additional, Tauhid, Lamiya, additional, Lilly, Jena V., additional, Mason, Jennifer L., additional, Farrow, Bailey, additional, Young, Nathan, additional, Leary, Sarah, additional, Moon, Jamie, additional, Petyuk, Vladislav A., additional, Nazarian, Javad, additional, Adappa, Nithin D., additional, Palmer, James N., additional, Lober, Robert M., additional, Rivero-Hinojosa, Samuel, additional, Wang, Liang-Bo, additional, Wang, Joshua M., additional, Broberg, Matilda, additional, Chu, Rosalie K., additional, Moore, Ronald J., additional, Monroe, Matthew E., additional, Zhao, Rui, additional, Smith, Richard D., additional, Zhu, Jun, additional, Robles, Ana I., additional, Mesri, Mehdi, additional, Boja, Emily, additional, Hiltke, Tara, additional, Rodriguez, Henry, additional, Zhang, Bing, additional, Schadt, Eric E., additional, Mani, D.R., additional, Ding, Li, additional, Iavarone, Antonio, additional, Wiznerowicz, Maciej, additional, Schürer, Stephan, additional, Chen, Xi S., additional, Heath, Allison P., additional, Rokita, Jo Lynne, additional, Nesvizhskii, Alexey I., additional, Fenyö, David, additional, Rodland, Karin D., additional, Liu, Tao, additional, Gygi, Steven P., additional, Paulovich, Amanda G., additional, Resnick, Adam C., additional, Storm, Phillip B., additional, Rood, Brian R., additional, Wang, Pei, additional, Francis, Alicia, additional, Morgan, Allison M., additional, Waanders, Angela J., additional, Viaene, Angela N., additional, Buccoliero, Anna Maria, additional, Chinnaiyan, Arul M., additional, Leonard, Carina A., additional, Kline, Cassie N., additional, Caporalini, Chiara, additional, Kinsinger, Christopher R., additional, Li, Chunde, additional, Kram, David E., additional, Hanson, Derek, additional, Appert, Elizabeth, additional, Kawaler, Emily A., additional, Raabe, Eric H., additional, Jackson, Eric M., additional, Greenfield, Jeffrey P., additional, Stone, Gabrielle S., additional, Getz, Gad, additional, Grant, Gerald, additional, Teo, Guo Ci, additional, Pollack, Ian F., additional, Cain, Jason E., additional, Foster, Jessica B., additional, Phillips, Joanna J., additional, Palma, July E., additional, Ketchum, Karen A., additional, Ruggles, Kelly V., additional, Blumenberg, Lili, additional, Cornwell, Macintosh, additional, Sarmady, Mahdi, additional, Domagalski, Marcin J., additional, Cieślik, Marcin P., additional, Santi, Mariarita, additional, Li, Marilyn M., additional, Ellis, Matthew J., additional, Wyczalkowski, Matthew A., additional, Connors, Meghan, additional, Scagnet, Mirko, additional, Gupta, Nalin, additional, Edwards, Nathan J., additional, Vitanza, Nicholas A., additional, Vaske, Olena M., additional, Becher, Oren, additional, McGarvey, Peter B., additional, Firestein, Ron, additional, Mueller, Sabine, additional, Winebrake, Samuel G., additional, Dhanasekaran, Saravana Mohan, additional, Cai, Shuang, additional, Partap, Sonia, additional, Patton, Tatiana, additional, Le, Toan, additional, Lorentzen, Travis D., additional, Liu, Wenke, additional, and Bocik, William E., additional

Published
2020
Full Text
View/download PDF

198. Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma.

Author

Tong, Charles C. L., Koptyra, Mateusz, Raman, Pichai, Rathi, Komal S., Choudhari, Namrata, Lin, Xiang, Seckar, Tyler, Wei, Zhi, Kohanski, Michael A., O'Malley, Bert W., Cohen, Noam A., Kennedy, David W., Adappa, Nithin D., Robertson, Erle S., Baranov, Esther, Kuan, Edward C., Papagiannopoulos, Peter, Jalaly, Jalal B., Feldman, Michael D., and Storm, Phillip B.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results